Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate bill would repeal competitive bidding demo

This article was originally published in The Gray Sheet

Executive Summary

A Senate bill (S. 2099) to repeal CMS' competitive bidding demonstration project for clinical laboratories is introduced Sept. 26 and applauded by the American Clinical Laboratory Association. ACLA is lobbying Sens. Max Baucus (D-Mont.) and Charles Grassley (R-Iowa) to attach language in the bill to a separate package of Medicare reform provisions that Congress is expected to consider this year. Introduced by Sens. Ken Salazar (D-Col.), Pat Roberts (R-Kan.) and Maria Cantwell (D-Wash.), the bill mirrors similar legislation in the House (H.R. 3453) to stop CMS from carrying out the demonstration project to assess the cost-saving potential of replacing Medicare's lab fee schedule with prices based on the lowest bids from labs ("1The Gray Sheet" Aug. 13, 2007, p. 8)

You may also be interested in...



Bill Would Stop Competitive Bidding Demonstration For Laboratory Services

A bill introduced in the House Aug. 4 would cancel a Medicare clinical laboratory services competitive bidding demonstration project before it begins

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel